Tainted Plasma Traced to Arkansas Prison: Bill Clinton's Blood Trails
Loaded on MAY 15, 1999 by St Clair, Jeffrey published in Prison Legal News May, 1999, page 1
Filed under: Misconduct/Corruption, Contractor Misconduct, Government Misconduct, Prison Industries, HIV/AIDS, Medical Experiments/Exploitation, Blood. Location: Arkansas.
Share:
Share on Twitter Share on Facebook Share on G+ Share with email by Jeffrey St. Clair
https://www.prisonlegalnews.org/news/1999/may/15/tainted-plasma-traced-to-arkansas-prison-bill-clintons-blood-trails/
The year Bill Clinton became governor of Arkansas, the Arkansas state prison board awarded a hefty contract to a Little Rock company called Health Management Associates (HMA). The company got $3 million a year to run medical services for the state's awful prison system, which had been excoriated in a ruling by the U.S. Supreme Court as an "evil place run by some evil men."
HMA not only made money from providing medical care to prisoners, but it also started a profitable side venture: blood mining. The company paid prisoners $7 a pint to have their blood drawn [about half what urban skid road blood suckers pay for winos' blood]. HMA then sold the blood on the international plasma market for $50 a pint, with half of that going to the Arkansas Department of Corrections.
Since Arkansas is one of the states that does not pay prisoners for their labor, prisoners were frequent donors at the so-called "blood clinic". Hundreds of prisoners sold as much as two pints a week to HMA. The blood was then sold to pharmaceutical companies, such as Bayer and Baxter International; to blood banks, such as the Red Cross; and to so-called blood fractionizers, which transform the blood into medicines for hemophiliacs.
HMA's contract with the Arkansas DOC and its entry into the blood market came at the same time as the rise of AIDS in the United States. Regardless, HMA did not screen the torrents of prison blood, even after the Food and Drug Administration issued special alerts about the higher incidence of AIDS and hepatitis in prison populations.
When American drug companies and blood fractionizers stopped buying blood taken from prisoners in the early 1980s, HMA turned to the international blood market, selling to companies in Italy, France, Spain and Japan. But the prime buyer of HMA's tainted blood, drawn largely from prisoners at the Cummings Unit in Grady, Arkansas, was a notorious Canadian firm, Continental Pharma Cryosan Ltd.
Cryosan had a shady reputation in the medical industry. It had been nabbed importing blood taken from Russian cadavers and relabeled as from Swedish volunteers. The company also marketed blood taken from Haitian slums.